Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473651 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of Lu AG06479 in Healthy Young Men
A Phase 1 study, sponsored by H. Lundbeck A/S.
- Terminated
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT04473651 is a Phase 1 study that was terminated before completion, run by H. Lundbeck A/S. The registered enrollment target is 46 participants.
The verdict
NCT04473651, a Phase 1 study, was terminated before completion, sponsored by H. Lundbeck A/S.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug.
Interventions
- DRUG Placebos
- DRUG Lu AG06479
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2021-11-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473651
The ClinicalTrials.gov registry entry for NCT04473651 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04473651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04473651 about?
NCT04473651 is a clinical study titled "Safety and Tolerability of Lu AG06479 in Healthy Young Men". The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug.
What is the current status of trial NCT04473651?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2020-07-09. Estimated completion is 2021-11-10.
What interventions are being tested in trial NCT04473651?
The interventions under investigation include: Placebos (DRUG), Lu AG06479 (DRUG).
Who is sponsoring clinical trial NCT04473651?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.